Efficacy and Safety Study of R935788 Tablets to Treat Rheumatoid Arthritis (Taski-3)
Public ClinicalTrials.gov record NCT00665626. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Dose Study of R935788 in Patients With Rheumatoid Arthritis Who Have Failed at Least One Biologic
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether the Spleen Tyrosine Kinase (Syk) Inhibitor, R935788 (R788) at a dose of 100 mg, tablet, orally, twice-a-day is effective in the treatment of Rheumatoid Arthritis in patients who have 'failed' a biologic therapy.
Study identification
- NCT ID
- NCT00665626
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Enrollment
- 219 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 30, 2008
- Primary completion
- May 31, 2009
- Completion
- May 31, 2009
- Last update posted
- Apr 30, 2017
2008 – 2009
United States locations
- U.S. sites
- 27
- U.S. states
- 16
- U.S. cities
- 27
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Arthritis & Rheumatic Disease Specialties | Aventura | California | 33180 | — |
| Desert Medical Advances | Palm Desert | California | 92260 | — |
| San Diego Arthritis & Medical Clinic | San Diego | California | 92108 | — |
| Department of Rheumatology | Washington D.C. | District of Columbia | 20010 | — |
| RASF-Clinical Research Center | Boca Raton | Florida | 33486 | — |
| Florida Medical Research Institute | Gainsville | Florida | 32607 | — |
| Paddock Park Clinical Research | Ocala | Florida | 34474 | — |
| Lovelace Scientific Resources | Sarasota | Florida | 34233 | — |
| Intermountain Orthopedics | Boise | Idaho | 83702 | — |
| Rheumatology Associates, SC | Chicago | Illinois | 60612 | — |
| Memorial Medical Group Clinical Research Inst | South Bend | Indiana | 46601 | — |
| Center for Arthritis & Osteoperosis | Elizabethtown | Kentucky | 42701 | — |
| The Osteoporosis & Clinical Trials Center | Cumberland | Maryland | 21502 | — |
| The Osteoporosis & Clinical Trials Center | Hagerstown | Maryland | 21740 | — |
| Fiechtner Research, Inc. | Lansing | Michigan | 48910 | — |
| Westroads Medical Group | Omaha | Nebraska | 68114 | — |
| North Shore Long Island Jewich Health System | Lake Success | New York | 11042 | — |
| Andrew Porges, MD PC | Roslyn | New York | 11576 | — |
| Rheumatology Associates of Long Island | Smithtown | New York | 11787 | — |
| Clinical Research Division | Mayfield Village | Ohio | 44143 | — |
| Health Research of Oklahoma | Oklahoma City | Oklahoma | 73103 | — |
| Rheumatology Associates | Erie | Pennsylvania | 16508 | — |
| Clinical Research Center of Reading, LLP | West Reading | Pennsylvania | 34474 | — |
| Rheumatic Disease Associates | Willow Grove | Pennsylvania | 19090 | — |
| Austin Rheumatology & Research | Austin | Texas | 78705 | — |
| Houston Institute for Clinical Research | Houston | Texas | 77074 | — |
| Arthritis Northwest, PLLC | Spokane | Washington | 99204 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 17 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00665626, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 30, 2017 · Synced Sep 2, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00665626 live on ClinicalTrials.gov.